ArticleCureus2024
Phytosterols and Benign Prostatic Hyperplasia Management: Knowledge and Perceptions Among Future Healthcare Professionals.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Benign prostatic hyperplasia (BPH) is a common condition in elderly men, with a growing global incidence. Dietary supplements containing phytosterols (DS-PS) are increasingly used as complementary treatments for BPH. However, there is limited understanding of the knowledge and perceptions future healthcare professionals have regarding these supplements, which may affect the quality of medical counseling and patient care. Aim The present study aims to obtain a clear and detailed understanding of the level of knowledge and existing perceptions among medical students regarding DS-PS used in BPH. Materials and methods A structured questionnaire based on 18 questions was distributed to students from the medicine and pharmacy programs of the George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Romania. Descriptive statistics was applied to all the questions, and potential associations were evaluated by the chi-square test. Results The study included 361 participants, predominantly female (54.61%) and aged between 18 and 25 years (82.06%). Although 80.43% of respondents were familiar with the concept of BPH, only 57.99% knew that phytosterols (PS) are used to improve the symptoms associated with BPH. A significant finding is that pharmacy students had a higher level of knowledge about DS-PS (79.77%) compared to medical students (54.49%). However, both groups show similar levels of general knowledge about BPH. Additionally, there was a significant association between the awareness of DS-PS and the perception of their safety, as well as between the level of knowledge about BPH and the understanding of the benefits offered by PS in the treatment of BPH (p<0.05). Conclusion This study shows a positive perception of PS among respondents, even in the absence of detailed knowledge, highlighting the need for integrative curricula for medical students and advanced training for healthcare professionals focused on the use of complementary phytotherapeutic approaches in chronic conditions. Integrating this information into university curricula and promoting evidence-based information could enhance clinical practice and patient counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.